SCM
CASC

Segantii Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Segantii Capital Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-58,647
Closed -$243K – 367
2017
Q1 		$243K Buy
+58,647
New +$243K 0.04% 127